GlaxoSmithKline PLC — Director's Dealing 2017

Feb 20, 2017

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 3318X

GlaxoSmithKline PLC

20 February 2017

GlaxoSmithKline plc (the 'Company')

Shares withheld or sold to meet tax liabilities

Following the vesting of the pre-tax awards granted in 2014 under the GlaxoSmithKline Deferred Annual Bonus Plan (DABP) on 16 February 2017 and as notified on 17 February 2017, the notifications that follow reflect changes in the interests of Persons Discharging Managerial Responsibilities (PDMRs) in American Depositary Shares (ADSs) of the Company arising from the withholding of ADSs to meet tax liabilities. 

Transaction notification

1.

Details of PDMR/person closely associated with them ('PCA')

a)

Name

Dr M M Slaoui

b)

Position/status

Chairman, Global Vaccines

c)

Initial notification/

amendment

Initial notification

2.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

GlaxoSmithKline plc

b)

LEI

5493000HZTVUYLO1D793

3.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted

a)

Description of the financial  instrument

GlaxoSmithKline plc American Depositary Shares ('ADSs')

ISIN: US37733W1053

b)

Nature of the transaction

The withholding of ADSs to meet tax liabilities further to the vesting of awards granted in 2014 under the Company's 2009 Deferred Annual Bonus Plan-Deferred Bonus and Matching Awards.

c)

Price(s) and volume(s)

Price(s)	Volume(s)
$40.57	9,237 (Deferred)
$40.57	3,249 (Matching)

d)

Aggregated information

Aggregated volume Price

12,486                                                                                

$40.57

e)

Date of the transaction

2017-02-16

f)

Place of the transaction

n/a

1.

Details of PDMR/person closely associated with them ('PCA')

a)

Name

Mr D E Troy

b)

Position/status

SVP & General Counsel

c)

Initial notification/

amendment

Initial notification

2.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

GlaxoSmithKline plc

b)

LEI

5493000HZTVUYLO1D793

3.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted

a)

Description of the financial  instrument

GlaxoSmithKline plc American Depositary Shares ('ADSs')

ISIN: US37733W1053 

b)

Nature of the transaction

The withholding of ADSs to meet tax liabilities further to the vesting of awards granted in 2014 under the Company's 2009 Deferred Annual Bonus Plan-Deferred Bonus and Matching Awards.

c)

Price(s) and volume(s)

Price(s)	Volume(s)
$40.57	3,280 (Deferred)
$40.57	1,208 (Matching)

d)

Aggregated information

Aggregated volume Price

4,488

$40.57

e)

Date of the transaction

2017-02-16

f)

Place of the transaction

n/a

This information is provided by RNS

The company news service from the London Stock Exchange

END

DSHZBLFLDLFBBBK